High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer

10.18632/oncotarget.10894

Saved in:

Bibliographic Details
Main Authors:	Wang, T, Srivastava, S, Hartman, M, Buhari, S.A, Chan, C.-W, Iau, P, Khin, L.W, Wong, A, Tan, S.-H, Goh, B.-C, Lee, S.-C
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2020
Subjects:	alpha smooth muscle actin beta1 integrin docetaxel doxorubicin estrogen receptor FN protein mammalian target of rapamycin oncoprotein SPARC protein THBS1 protein TNC protein unclassified drug MTOR protein, human target of rapamycin kinase tenascin thrombospondin 1 thrombospondin-1, human Article breast cancer breast surgery cancer adjuvant therapy cancer growth cancer resistance cancer survival clinical feature cohort analysis controlled study drug efficacy female human human tissue immunohistochemistry major clinical study MCF 7 cell line multiple cycle treatment outcome assessment overall survival phase 2 clinical trial prediction protein determination protein expression protein function randomized controlled trial tumor biopsy upregulation adult aged breast tumor chemistry drug resistance middle aged mortality pathology physiology signal transduction tumor cell line Adult Aged Breast Neoplasms Cell Line, Tumor Drug Resistance, Neoplasm Female Humans Integrin beta1 Middle Aged Signal Transduction Tenascin Thrombospondin 1 TOR Serine-Threonine Kinases
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/174109
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-174109
record_format	dspace
spelling	sg-nus-scholar.10635-1741092024-04-25T02:39:04Z High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer Wang, T Srivastava, S Hartman, M Buhari, S.A Chan, C.-W Iau, P Khin, L.W Wong, A Tan, S.-H Goh, B.-C Lee, S.-C CANCER SCIENCE INSTITUTE OF SINGAPORE MEDICINE SURGERY DEAN'S OFFICE (MEDICINE) PHARMACOLOGY alpha smooth muscle actin beta1 integrin docetaxel doxorubicin estrogen receptor FN protein mammalian target of rapamycin oncoprotein SPARC protein THBS1 protein TNC protein unclassified drug beta1 integrin MTOR protein, human target of rapamycin kinase tenascin thrombospondin 1 thrombospondin-1, human Article breast cancer breast surgery cancer adjuvant therapy cancer growth cancer resistance cancer survival clinical feature cohort analysis controlled study drug efficacy female human human tissue immunohistochemistry major clinical study MCF 7 cell line multiple cycle treatment outcome assessment overall survival phase 2 clinical trial prediction protein determination protein expression protein function randomized controlled trial tumor biopsy upregulation adult aged breast tumor chemistry drug resistance middle aged mortality pathology physiology signal transduction tumor cell line Adult Aged Breast Neoplasms Cell Line, Tumor Drug Resistance, Neoplasm Female Humans Integrin beta1 Middle Aged Signal Transduction Tenascin Thrombospondin 1 TOR Serine-Threonine Kinases 10.18632/oncotarget.10894 Oncotarget 7 34 55155-55168 2020-09-03T10:31:43Z 2020-09-03T10:31:43Z 2016 Article Wang, T, Srivastava, S, Hartman, M, Buhari, S.A, Chan, C.-W, Iau, P, Khin, L.W, Wong, A, Tan, S.-H, Goh, B.-C, Lee, S.-C (2016). High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer. Oncotarget 7 (34) : 55155-55168. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.10894 19492553 https://scholarbank.nus.edu.sg/handle/10635/174109 Unpaywall 20200831
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	alpha smooth muscle actin beta1 integrin docetaxel doxorubicin estrogen receptor FN protein mammalian target of rapamycin oncoprotein SPARC protein THBS1 protein TNC protein unclassified drug beta1 integrin MTOR protein, human target of rapamycin kinase tenascin thrombospondin 1 thrombospondin-1, human Article breast cancer breast surgery cancer adjuvant therapy cancer growth cancer resistance cancer survival clinical feature cohort analysis controlled study drug efficacy female human human tissue immunohistochemistry major clinical study MCF 7 cell line multiple cycle treatment outcome assessment overall survival phase 2 clinical trial prediction protein determination protein expression protein function randomized controlled trial tumor biopsy upregulation adult aged breast tumor chemistry drug resistance middle aged mortality pathology physiology signal transduction tumor cell line Adult Aged Breast Neoplasms Cell Line, Tumor Drug Resistance, Neoplasm Female Humans Integrin beta1 Middle Aged Signal Transduction Tenascin Thrombospondin 1 TOR Serine-Threonine Kinases
spellingShingle	alpha smooth muscle actin beta1 integrin docetaxel doxorubicin estrogen receptor FN protein mammalian target of rapamycin oncoprotein SPARC protein THBS1 protein TNC protein unclassified drug beta1 integrin MTOR protein, human target of rapamycin kinase tenascin thrombospondin 1 thrombospondin-1, human Article breast cancer breast surgery cancer adjuvant therapy cancer growth cancer resistance cancer survival clinical feature cohort analysis controlled study drug efficacy female human human tissue immunohistochemistry major clinical study MCF 7 cell line multiple cycle treatment outcome assessment overall survival phase 2 clinical trial prediction protein determination protein expression protein function randomized controlled trial tumor biopsy upregulation adult aged breast tumor chemistry drug resistance middle aged mortality pathology physiology signal transduction tumor cell line Adult Aged Breast Neoplasms Cell Line, Tumor Drug Resistance, Neoplasm Female Humans Integrin beta1 Middle Aged Signal Transduction Tenascin Thrombospondin 1 TOR Serine-Threonine Kinases Wang, T Srivastava, S Hartman, M Buhari, S.A Chan, C.-W Iau, P Khin, L.W Wong, A Tan, S.-H Goh, B.-C Lee, S.-C High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
description	10.18632/oncotarget.10894
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Wang, T Srivastava, S Hartman, M Buhari, S.A Chan, C.-W Iau, P Khin, L.W Wong, A Tan, S.-H Goh, B.-C Lee, S.-C
format	Article
author	Wang, T Srivastava, S Hartman, M Buhari, S.A Chan, C.-W Iau, P Khin, L.W Wong, A Tan, S.-H Goh, B.-C Lee, S.-C
author_sort	Wang, T
title	High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
title_short	High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
title_full	High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
title_fullStr	High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
title_full_unstemmed	High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
title_sort	high expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/174109
_version_	1800914214552862720

High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer

Similar Items